Skip to content

Dr. L. Poppeliers

Active Private limited companyfounded 2020active for 6 yearsDiepenbeekvelde 47, 2150 AntwerpKBO/BCE: BE 0744.448.373

Lifetime

6 annual accounts with figures on one time axis
peak of €194,659 in 2024
€185,597▼ 4.7%
peak of €145,428 in 2024
€139,949▼ 3.8%
peak of €110,218 in 2022
€10,000▼ 82.5%
€200,050▲ 16.8%
Board1 name since 2020
1 director
Documentsfilings and deeds
03-07-202628 days before the deadline
2025micro format
Dividend €187,184Equity from €57,235 to €10,000Debts from €171,257 to €200,050

Key points

from the 2025 annual accounts

Equity

€10,000 from €110,218 in 2022

Equity fell by 91% in 3 years.

Turnover

≈ €350,000 estimated

The micro format states no turnover.

Debts

€200,050 95% of the balance sheet
After one year 1%Within one year 99%

Of this, €197,394 falls due within a year.

Filings

6 annual accounts since 2020
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 8 to 32 days before the end of the period.

Position in the sector

4.8%

Lower solvency than 89% of companies in human health. Sector median 63.0% · 21,347 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Dr. L. Poppeliers has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Dr. L. Poppeliers. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-02-2020
  • 100 sharesdeed of 27-02-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0744448373
First establishment Diepenbeekvelde 47, Antwerp
Incorporation Founding capital of €10,000, 100 shares · Founded by · acts as permanent representative · published on 27-02-2020 · Gazette deed
All 11 events

Comparable companies

same main activity, similar in size and age
Company
Dr. L. Poppeliers Antwerp €210,050 €185,597 4.8% -
Dr. Sebastiaan Tuyls Antwerp €189,452 €182,797 4.0% -
Dokter Pepijn Mooren Antwerp €187,314 €191,633 18.8% -
DR. DE MUYNCK BENEDICTE Antwerp €195,177 €171,795 2.6% -
Dr. Pieter-Jan Geselle-cardioloog Waregem €223,951 €188,833 25.1% -
DR. CHRISTOPHE DE MEESTER Alken €215,174 €187,106 64.0% -
GERALDINE DELNOOZ ANESTHESIE La Bruyère €212,660 €176,464 0.9% -

These companies have the same main activity as Dr. L. Poppeliers: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €187,000 and €224,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 25-02-2020Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.300.435.4692150 Antwerp, since 01-03-2020
Financial year end
31 December
Peppol
Reachable since 09-11-2025
Company details

Annual accounts 2025

€210,050▼ 8.1%
Filing
Filed on 03-07-2026, 28 days before the end of the filing period
Financials

Insights on Dr. L. Poppeliers

Dr. L. Poppeliers files the micro format. That format states no turnover. The gross margin rose from €9,702 in 2020 to €185,597 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. L. Poppeliers

What is the company number of Dr. L. Poppeliers?
The company number of Dr. L. Poppeliers is 0744.448.373. The VAT number is the same number with BE in front: BE 0744.448.373.
Where is Dr. L. Poppeliers based?
The registered office is at Diepenbeekvelde 47, 2150 Antwerp.Company details
What does Dr. L. Poppeliers do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. L. Poppeliers?
Dr. L. Poppeliers is a private limited company (BV).
When was Dr. L. Poppeliers founded?
Dr. L. Poppeliers was founded on 25-02-2020.
Is Dr. L. Poppeliers still active?
Yes, Dr. L. Poppeliers is an active enterprise in the KBO register.
What is the turnover of Dr. L. Poppeliers?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €185,597 and 40 comparable companies (NACE 86220). It probably lies between €290,000 and €460,000.Financials
Is Dr. L. Poppeliers profitable?
In financial year 2025, Dr. L. Poppeliers made a profit of €139,949.
Where can I find the annual accounts of Dr. L. Poppeliers?
Dr. L. Poppeliers filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. L. Poppeliers due?
Dr. L. Poppeliers must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.